Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.840
-0.320 (-10.13%)
At close: Nov 20, 2024, 4:00 PM
2.860
+0.020 (0.70%)
Pre-market: Nov 21, 2024, 7:27 AM EST
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2024. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$1,354,700
Profits / Employee
-$368,600
Market Cap
3.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Check-Cap | 85 |
| Biofrontera | 85 |
| Genetic Technologies | 55 |
| Predictive Oncology | 35 |
| Hepion Pharmaceuticals | 22 |
| Windtree Therapeutics | 20 |
| Galmed Pharmaceuticals | 8 |
| Pasithea Therapeutics | 8 |
SNOA News
- 9 days ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Accesswire
- 13 days ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - Accesswire
- 20 days ago - Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution - Accesswire
- 2 months ago - Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line - Accesswire